Actively Recruiting

Phase Not Applicable
Age: 50Years - 70Years
FEMALE
NCT05968677

Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients

Led by Flavolife Srl · Updated on 2025-03-14

60

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare the effect of a Food for Special Medical Purposes (FSMP) mainly containing amino acids and flavonoids in combination with nutritional counseling, versus nutritional counseling alone, on chemotherapy toxicity, nutritional status and quality of life in patients with breast cancer. The main questions it aims to answer are: * can this dietary supplementation affect the nutritional status of breast cancer patients? * can this dietary supplementation have any beneficial effect on chemotoxicity? Participants will be asked to undergo nutritional counseling and to take the study product every day for 12 weeks. Researchers will compare a similar group of participants only receiving the nutritional counseling to see if any difference occurs.

CONDITIONS

Official Title

Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients

Who Can Participate

Age: 50Years - 70Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of non-metastatic ductal breast cancer
  • Post-menopausal women
  • Scheduled chemotherapy with Doxorubicin or Epirubicin, with or without Cyclophosphamide, as adjuvant or neo-adjuvant
  • Provided written informed consent
  • Able to eat independently by mouth
  • Able to attend periodic study visits
Not Eligible

You will not qualify if you...

  • Receiving artificial feeding
  • Eastern Cooperative Oncology Group (ECOG) performance status greater than 2
  • Unable to undergo required measurements
  • Presence of other tumor diseases
  • Previous therapy with Doxorubicin or Epirubicin
  • Currently receiving molecular targeted therapies
  • History of chronic kidney, liver, or heart failure
  • History of mental disorders
  • Known allergies or intolerances to any study product ingredient
  • Participation in other interventional clinical trials within the past three months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCSS San Matteo University Hospital Foundation

Pavia, Italy

Actively Recruiting

Loading map...

Research Team

P

Paolo Pedrazzoli, MD

CONTACT

E

Emanuele Cereda, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here